Benzinga Psychedelics Capital Conference 2023

At this year's Benzinga Psychedelics Capital Conference, firm partner Nadav Aschner spoke on the current legal intricacies of psychedelics at the "Oregon, Colorado, Quebec: Lessons from legal psilocybin markets" panel. Beginning with the regulatory strategies employed by psychedelics on their path … Read more about Benzinga Psychedelics Capital Conference 2023

Psychedelic Medicine’s Rise in 2019

Late March of 2019, a collection of European technology investors made waves in the psychedelic medicine industry, amassing the largest-ever private financing round for biotech company, ATAI Life Sciences (“ATAI”). According to ATAI’s press release, the German-based company’s Series B financing … Read more about Psychedelic Medicine’s Rise in 2019

MDMA-Assisted Psychotherapy Study Expands Screening

Multidisciplinary Association for Psychedelic Studies (“MAPS”), a non-profit research, advocacy, and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and empathogens, has recently announced the expansion of their … Read more about MDMA-Assisted Psychotherapy Study Expands Screening